Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients

Clinical Neuropharmacology

Volumn 23, Issue 4, 2000, Pages 190-194

  Di Rocco, Alessandro ^a   Bottiglieri, Teodoro ^c   Dorfman, David ^b   Werner, Peter ^a   Morrison, Chris ^b   Simpson, David ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Baylor Metabolic Institute   (United States)

Author keywords

AIDS; Dementia; Dopamine

Indexed keywords

DOPAMINE; HOMOVANILLIC ACID;

ADULT; ARTICLE; ATTENTION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEMORY; MENTAL FUNCTION; MENTAL PERFORMANCE; METABOLITE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HOMOVANILLIC ACID; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 0033797076     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200007000-00004     Document Type: Article

References (29)

1. The AIDS dementia complex - I: Clinical features
2. Excitotoxicity and dopaminergic dysfunction in the Acquired Immunodeficiency Syndrome Dementia Complex: Therapeutic implications
3. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type 1 (HIV-1) infection
4. Cognitive function in Parkinson's disease: From description to theory
5. Subcortical dementia
6. Intellectual impairment in Parkinson's disease: Clinical, pathologic, and biochemical correlates
7. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy
8. Persistent neuroloeptic-induced rigidity and dystonia in AIDS dementia complex: A clinico-pathologic case report
9. Nigral degeneration in acquired immune deficiency syndrome (AIDS)
10. HIV dementia and the basal ganglia
11. Cerebrospinal fluid dopamine in HIV infection
12. The metabolic pathology of the AIDS dementia complex
13. Abnormal glucose metabolism in HIV-1 seropositive subjects with and without dementia
14. Deep grain matter structers in HIV infection: A proton MR spectroscopy study
15. Cerebrospinal fluid cathecolamine metabolites in HIV-infected patients
16. Zidovudine treatment of the AIDS dementia complex: Results of a placebo-controlled trial. AIDS Clinical Trials Group
17. Age effect on dopamine and serotonin metabolite levels in cerebrospinaI fluid
18. Dopamine dificit in the brain: The biochemical basis of parkinsonian symptoms in AIDS
19. Monoamine metabolites levels in CSF of SIV-infected rhesus monkeys (macaca mulatta)
20. Neuropsychological features of HIV disease
21. Neuropsychological findings in HIV-1 disease and AIDS
22. Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery
23. Dementia and cognitive changes in Huntington's disease
24. The 'subcortical dementia' of progressive supranuclear palsy
25. Movement disorders and AIDS
26. The AIDS dementia complex: II - Neuropathology
27. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
28. The neuropathogenesis of AIDS dementia complex
29. Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes